Work

Safety and tolerability of intraventricular CARv3-TEAM-E T cells following lymphodepleting chemotherapy in recurrent glioblastoma: INCIPIENT trial.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.2017

Authors: Elizabeth R. Gerstner, William T. Curry, Deborah Anne Forst, Alona Muzikansky, Estelle Emmanuel-Alejandro, Gabrielle Furman, Daniella Cook, Danielle Bernier, Lu Huang, Jeremy Ford, Karen Buch, Sarah Nikiforow, Kathleen Gallagher, Matthew J. Frigault, Marcela Valderrama Maus, Bryan D. Choi

Institutions: Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410819465

Cites:

Cited by: 2

Related to: 10